STOCK TITAN

Aramark (NYSE: ARMK) director granted 36.644 dividend-equivalent shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Aramark director Brian M. DelGhiaccio reported an acquisition of 36.644 shares of common stock-equivalent rights on June 3, 2026. The Form 4 describes these as dividend equivalent rights that accrued on deferred stock units he already holds, tied to Aramark’s regular quarterly dividend.

These rights were granted at no cash cost and vest on the same schedule as the underlying deferred stock unit awards. Following this award, DelGhiaccio’s direct holdings reported in this filing total 16,385.995 shares of Aramark common stock.

Positive

  • None.

Negative

  • None.
Insider DelGhiaccio Brian M
Role null
Type Security Shares Price Value
Grant/Award Common Stock 36.644 $0.00 --
Holdings After Transaction: Common Stock — 16,385.995 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 36.644 shares Dividend equivalent rights credited on June 3, 2026
Post-transaction holdings 16,385.995 shares Direct Aramark common stock holdings after award
Grant price $0.00 per share Reported transaction price for dividend equivalent rights
Transaction code A (Grant, award, or other acquisition) Non-derivative Form 4 transaction classification
dividend equivalent rights financial
"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
deferred stock units financial
"accrued to the reporting person on deferred stock units held by the reporting person"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Grant, award, or other acquisition regulatory
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DelGhiaccio Brian M

(Last)(First)(Middle)
C/O ARAMARK
2400 MARKET STREET

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A36.644(1)A$016,385.995D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
Remarks:
/s/ Ryan S. Spengler, as Attorney-in-fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Aramark (ARMK) report for Brian M. DelGhiaccio?

Aramark reported that director Brian M. DelGhiaccio received 36.644 common stock-equivalent dividend rights. These accrued on deferred stock units he holds, reflecting Aramark’s quarterly dividend, and were granted at no cash cost as additional compensation.

How many Aramark (ARMK) shares does Brian M. DelGhiaccio hold after this Form 4?

After this transaction, Brian M. DelGhiaccio is reported as directly holding 16,385.995 shares of Aramark common stock. This figure includes the newly accrued 36.644 dividend equivalent rights linked to his existing deferred stock unit awards.

What are dividend equivalent rights in the Aramark (ARMK) Form 4 filing?

Dividend equivalent rights are additional stock-linked units that accrue when Aramark pays its quarterly dividend. In this filing, they accrued on DelGhiaccio’s deferred stock units and will vest on the same schedule as the underlying deferred stock unit awards.

Was Brian M. DelGhiaccio’s Aramark (ARMK) transaction an open-market stock purchase?

No, the Form 4 identifies the transaction as a grant or award acquisition. The 36.644 shares represent dividend equivalent rights credited on deferred stock units, with a reported price of $0.00 per share rather than an open-market purchase.

Do the Aramark (ARMK) dividend equivalent rights vest immediately for Brian M. DelGhiaccio?

The filing states that the dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards. This means vesting follows the pre-existing timelines of those awards, rather than occurring immediately upon accrual.